TAMOXIFEN-INDUCED IMMUNE-MEDIATED PLATELET DESTRUCTION - A CASE-REPORT

Citation
A. Candido et al., TAMOXIFEN-INDUCED IMMUNE-MEDIATED PLATELET DESTRUCTION - A CASE-REPORT, Tumori, 79(3), 1993, pp. 231-234
Citations number
17
Categorie Soggetti
Oncology
Journal title
TumoriACNP
ISSN journal
03008916
Volume
79
Issue
3
Year of publication
1993
Pages
231 - 234
Database
ISI
SICI code
0300-8916(1993)79:3<231:TIPD-A>2.0.ZU;2-6
Abstract
Drug-induced immunologic thrombocytopenia, a fairly common disorder, i s characterized by drug-dependent antiplatelet antibodies that destroy circulating platelets in the presence of the provoking drug or its me tabolites. The development of reliable methods for the detection of pl atelet-bound immunoglobulins causing in vivo platelet destruction, suc h as the use of monoclonal antibodies tagged with fluorescein and flow cytofluorimetric analysis, has ushered in a new era to differentiate between immune and non-immune thrombocytopenias. A severe thrombocytop enia developed in an elderly female patient treated with tamoxifen, a non-steroidal anti-estrogen drug, after surgery for breast cancer. A t amoxifen-dependent platelet antibody was detected in the patient's ser um and linked on the platelet membranes. This antibody reacted only in the presence of the offending drug and showed platelet specificity. W ithdrawal of drug restored platelet count to normal levels.